Uncategorized
Ophthotech reports $7.6 million net income in first quarter
Ophthotech reported net income of $7.6 million, or $0.22 per diluted share, in the first quarter 2015 compared with a net loss of $20.7 million, or $0.64 per diluted share, in the first quarter 2014, according to a press release.Collaboration revenue was $41.7 million in the first quarter. Revenue was related to a $50 million enrollment-based milestone from Novartis based on the Fovista phase 3 clinical program, the release said. No collaboration revenue was recorded in the first quarter 2014.